As of 2025-12-18, the Intrinsic Value of Pangenomic Health Inc (NARA.CN) is -0.66 CAD. This NARA.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.62 CAD, the upside of Pangenomic Health Inc is -206.79%.
Based on its market price of 0.62 CAD and our intrinsic valuation, Pangenomic Health Inc (NARA.CN) is overvalued by 206.79%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.66 - -0.66 | -0.66 | -206.79% |
| DDM - Stable | (0.43) - (0.79) | (0.61) | -198.2% |
| DDM - Multi | (0.66) - (0.96) | (0.79) | -226.9% |
| Market Cap (mil) | 8.62 |
| Beta | 2.58 |
| Outstanding shares (mil) | 13.90 |
| Enterprise Value (mil) | 8.74 |
| Market risk premium | 5.10% |
| Cost of Equity | 22.31% |
| Cost of Debt | 5.00% |
| WACC | 13.00% |